# Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis

> **NCT02185456** · EARLY_PHASE1 · UNKNOWN · sponsor: **Wayne State University** · enrollment: 200 (estimated)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** 750 mg metronidazole/ 200 mg miconazole vaginal suppository
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT02185456
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185456, "Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02185456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*